News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Spinal fluid analysis could speed up diagnosis of breast cancer spread
Analysing cancer DNA in spinal fluid could speed up and improve the diagnosis of breast cancer which has spread to the brain and spinal cord, according to a new pilot study.
Cancer Research UK renew support for Convergence Science Centre
Renewed Cancer Research UK funding for Convergence Science Centre at the ICR and Imperial will build on existing partnership by uniting cancer researchers with engineers and physical scientists to tackle cancer’s toughest challenges.
ESMO Virtual Plenary 2022: Major trial shows targeted drug improves survival in early-stage breast cancer with inherited BRCA1 or BRCA2 mutation
The ICR strongly welcomes new findings that the targeted drug olaparib improves survival in women with high-risk, early-stage breast cancer who have inherited faults in their BRCA1 or BRCA2 genes.
#BreakTheBias: Scientists showcase their lives outside the lab
What do scientists look like? This International Women’s Day, we are introducing some of our researchers to help #BreakTheBias, and showcasing the full lives and passions of our scientists outside the lab – from dancing and baking to running or playing an instrument.
New home for innovative life-science companies opens at The London Cancer Hub
A new incubator and collaboration space for innovative life-science companies whose work is relevant to cancer is opening its doors at The London Cancer Hub in Sutton, south London.
NHS gene testing does not detect half of people at cancer risk
NHS guidelines for gene testing miss half of people carrying inherited genetic changes linked to cancer, a new study reports.
NICE misses golden opportunity to enhance access to innovative cancer drugs
Cancer patients will miss out on exciting new treatments after NICE passed up a golden opportunity to ensure its evaluation methods support approval of the most innovative, potentially game-changing drugs.
Focused sound waves and immunotherapy combination shows promise in pancreatic cancers
Combining targeted, focused ultrasound and immunotherapy drugs could work as a new treatment for pancreatic cancers, a new study has shown.
ICR ranks top in UK for student satisfaction
Students on our MSc taught course and postgraduate research degree programmes have again ranked The Institute of Cancer Research, London, top nationally for student satisfaction in their respective surveys.
World Cancer Day: how our new virtual centre will enhance global cancer research and tackle inequality
The Centre for Global Oncology will help to to connect and develop cancer scientists around the world.
Study uncovers how cancers resist targeted treatment
Scientists have revealed how cancer can resist PARP inhibitors, a precision medicine used to treat thousands of patients worldwide.
ICR responds to NICE decision not to recommend olaparib for advanced prostate cancer
The Institute of Cancer Research, London, has expressed disappointment that NICE has decided not to recommend olaparib for previously treated, hormone-relapsed metastatic prostate cancer.
